The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.51
Ask: 0.54
Change: 0.00 (0.00%)
Spread: 0.03 (5.882%)
Open: 0.53
High: 0.53
Low: 0.525
Prev. Close: 0.525
TORO Live PriceLast checked at -
Chenavari Toro Income is an Investment Trust

To deliver an absolute return primarily investing and trading in ABS and other structured credit investments in liquid markets, and investing in asset backed transactions including through the origination of credit portfolios.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Investor Webinar

30 Jan 2024 07:01

RNS Number : 2859B
Chenavari Toro Income Fund Limited
30 January 2024
 

Chenavari Toro Income Fund Limited (the Company)

30 January 2024

Quarterly Investor Webinar

 

The Company announces that it will be hosting the next quarterly performance attribution call to discuss the Company's Q4 2023 performance and outlook:

Date: Thursday, 8 February 2024

Time: 14:00 GMT

 

In order to register your interest for the call and receive a copy of the dial in details please visit the following link:

https://www.chenavaritoroincomefund.com/fund-documents/quarterly-attribution-calls/dial-in-details/

Attendance will be limited to Professional Investors

Further information in relation to the Company is available at:

http://www.chenavaritoroincomefund.com

 

Enquiries:

Guy Goyard

Chenavari Investment Managers

Email: tlir@chenavari.com

Telephone: +44 20 7259 3600

 

This material is not for distribution to retail clients and is directed exclusively to Chenavari Investment Managers' Professional Clients and Eligible Counterparties, as defined in the Markets in Financial Instruments Directive (2004/39/ EC) Article 4(1) (12); investors who are U.S. Persons and Accredited Investors within the meaning of Regulation D under the U.S. Securities Act of 1933, as amended, or Qualified Purchasers within the meaning of Section 3(C)(7) of the U.S. Investment Company Act of 1940, as amended. Chenavari Investment Managers is the trading name of Chenavari Credit Partners LLP ("CCP") and Chenavari Investment Managers (Luxembourg) S.à.r.l is the AIFM ("CIM Lux" and together with CCP, "Chenavari"). The information contained herein is confidential information supplied at the sole request of the recipient. By accepting this information, the recipient agrees that it will not divulge any such information to any other party. Any reproduction of this information, in whole or in part, is prohibited. The distribution of this document in certain jurisdictions may be restricted by law; therefore, people into whose possession this document comes should inform themselves about and observe any such restrictions. It does not take into account the particular investment objectives, financial situation, risk appetite, tax status or needs of individual clients. Chenavari disclaims any and all liability relating to a decision based on or for reliance on this document.

This document has been prepared for general information purposes only and has not been delivered for registration in any jurisdiction, nor has its content been reviewed by any regulatory authority in any jurisdiction. The information contained herein does not constitute: (i) a binding legal agreement; (ii) legal, regulatory, tax, accounting or other advice; (iii) an offer, recommendation or solicitation to buy or sell shares in any fund or any security, commodity, financial instrument or derivative linked to, or otherwise included in, a portfolio managed or advised by Chenavari; or (iv) an offer to enter into any other transaction whatsoever. This document does not constitute due diligence reporting and Chenavari bears no responsibility for your investment research and/or investment decisions, nor will Chenavari be liable of any decision made or actions taken by you or others based on the contents of this document and neither Chenavari nor any of its directors, officers, employees or representatives accept any liability whatsoever for any loss or damage of any kind and howsoever arising.

The information, estimates, forecasts or opinions supplied by Chenavari in this document are supplied for your private use and information, and for discussion purposes only and do not constitute and may not be used for the purposes of, an offer to sell or the solicitation of an offer to buy nor shall there be any sale of units or shares issued by a fund managed or promoted by Chenavari or its affiliates in any jurisdiction in which such offer, solicitation or sale would be unlawful. The units or shares issued by a fund managed or promoted by Chenavari are offered or otherwise made available only in accordance with available, applicable private placement or offering rules. The information supplied by Chenavari or its affiliates and contained herein shall not be deemed to constitute investment advice and should not be relied upon as the basis for a decision to enter into a transaction or as the basis for an investment in units or shares issued by a fund managed or promoted by Chenavari or its affiliates as an investment in funds units of these funds may not be suitable or lawful for all investors.

Prospective investors should: (i) consult their financial, accounting, tax and legal advisors prior to any investment in units or shares issued by a fund managed or promoted by Chenavari; and (ii) inform themselves as to (a) the appropriateness of said investment in units or shares, (b) the legal requirements within their own jurisdictions for the purchase or holding of said investment, (c) any foreign exchange restrictions which may affect them, and (d) the income and other tax consequences which may apply in their own jurisdictions relevant to the purchase, holding or disposal of units or shares of the relevant fund or investment vehicle.

Chenavari makes no representation or warranty, express or implied, as to, or assumes any liability responsibility for, the accuracy, reliability or completeness of any information, so obtained and supplied, or any information, estimates, forecasts or opinions prepared on the basis of such information. Furthermore, Chenavari shall not be under any obligation or assume any liability towards any person to update or correct any inaccuracy or incompleteness of the information, estimates, forecasts or opinions prepared on the basis of such information. Chenavari shall not be in any way responsible, or assume any liability for, any act or omission made by any person in reliance on this document or any information contained herein. This document shall not in any event be deemed to be complete and exhaustive information on the subjects covered. Chenavari makes no representations and/or warrants that contained in this document is either up to date and/or accurate and expressly disclaims all liability for errors and/or omissions. The information contained in the document is not related to any particular investment objective, financial position or specific interest of any recipient and is not intended to be relied upon or used by any counterparty, investor or other party.

Where indicated, the information sourced relating to Chenavari or its affiliates has been provided for information or illustration purpose only, and Chenavari nor its affiliates shall not be held responsible for the content of such information. Although some information has been provided by Chenavari, the information is based on information furnished by third parties, the accuracy and completeness of which has not been verified by Chenavari or any other person.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABCGDBBSDDGSC
Date   Source Headline
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20245:00 pmRNSCompany Factsheet Available
27th Mar 20245:00 pmRNSNet Asset Value(s)
8th Mar 20241:00 pmRNSResult of AGM
7th Mar 20245:00 pmRNSShares in Issue
29th Feb 20247:00 amRNSCompany Factsheet Available
26th Feb 20245:00 pmRNSNet Asset Value(s)
15th Feb 20245:00 pmRNSScrip Dividend Election Price
8th Feb 20247:00 amRNSNotice of AGM
31st Jan 20247:00 amRNSCompany Factsheet Available
30th Jan 20247:01 amRNSQuarterly Investor Webinar
30th Jan 20247:00 amRNSDividend Declaration
25th Jan 20247:00 amRNSNet Asset Value(s)
5th Jan 20247:00 amRNSCompany Factsheet Available
2nd Jan 20247:00 amRNSTotal Voting Rights
28th Dec 20237:00 amRNSAnnual Report and Audited Financial Statements
22nd Dec 20237:01 amRNSShares in Issue
18th Dec 20237:00 amRNSNet Asset Value(s)
8th Dec 20235:00 pmRNSShares in Issue
29th Nov 20237:00 amRNSCompany Factsheet Available
22nd Nov 202310:30 amRNSNet Asset Value(s)
16th Nov 20235:00 pmRNSScrip Dividend Election Price
3rd Nov 20237:05 amRNSQuarterly Investor Webinar
27th Oct 20235:00 pmRNSCompany Factsheet Available
27th Oct 20237:00 amRNSDividend Declaration
26th Oct 20237:00 amRNSNet Asset Value(s)
2nd Oct 20237:00 amRNSTotal Voting Rights
29th Sep 20237:00 amRNSCompany Factsheet Available
21st Sep 20235:00 pmRNSNet Asset Value(s)
8th Sep 20235:00 pmRNSShares in Issue
29th Aug 20237:00 amRNSCompany Factsheet Available
21st Aug 20235:00 pmRNSNet Asset Value(s)
17th Aug 20235:00 pmRNSScrip Dividend Election Price
28th Jul 20237:00 amRNSDividend Declaration
27th Jul 20237:00 amRNSCompany Factsheet Available
21st Jul 20237:00 amRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSCompany Factsheet Available
28th Jun 20235:00 pmRNSInterim Financial Statements
22nd Jun 202311:00 amRNSNet Asset Value(s)
9th Jun 20235:00 pmRNSShares in Issue
1st Jun 20237:00 amRNSCompany Factsheet Available
23rd May 20235:45 pmRNSNet Asset Value(s)
18th May 20235:00 pmRNSScrip Dividend Election Price
28th Apr 20235:00 pmRNSCompany Factsheet Available
28th Apr 20237:01 amRNSDirectorate Change
28th Apr 20237:00 amRNSDividend Declaration
26th Apr 20236:25 pmRNSNet Asset Value
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20235:00 pmRNSCompany Factsheet Available

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.